Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022;20(3):1537-1545.
doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27.

The Fear of COVID-19 Scale: Development and Initial Validation

Daniel Kwasi Ahorsu  1 , Chung-Ying Lin  1 , Vida Imani  2 , Mohsen Saffari  3 , Mark D Griffiths  4 , Amir H Pakpour  5   6
Affiliations
Case Reports

The Fear of COVID-19 Scale: Development and Initial Validation

Daniel Kwasi Ahorsu et al. Int J Ment Health Addict. 2022.

Abstract

Background: The emergence of the COVID-19 and its consequences has led to fears, worries, and anxiety among individuals worldwide. The present study developed the Fear of COVID-19 Scale (FCV-19S) to complement the clinical efforts in preventing the spread and treating of COVID-19 cases.

Methods: The sample comprised 717 Iranian participants. The items of the FCV-19S were constructed based on extensive review of existing scales on fears, expert evaluations, and participant interviews. Several psychometric tests were conducted to ascertain its reliability and validity properties.

Results: After panel review and corrected item-total correlation testing, seven items with acceptable corrected item-total correlation (0.47 to 0.56) were retained and further confirmed by significant and strong factor loadings (0.66 to 0.74). Also, other properties evaluated using both classical test theory and Rasch model were satisfactory on the seven-item scale. More specifically, reliability values such as internal consistency (α = .82) and test-retest reliability (ICC = .72) were acceptable. Concurrent validity was supported by the Hospital Anxiety and Depression Scale (with depression, r = 0.425 and anxiety, r = 0.511) and the Perceived Vulnerability to Disease Scale (with perceived infectability, r = 0.483 and germ aversion, r = 0.459).

Conclusion: The Fear of COVID-19 Scale, a seven-item scale, has robust psychometric properties. It is reliable and valid in assessing fear of COVID-19 among the general population and will also be useful in allaying COVID-19 fears among individuals.

Keywords: COVID-19; Fear; Fear of COVID-19 Scale; Iran; Psychometrics.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe authors declare that they do not have any interests that could constitute a real, potential or apparent conflict of interest with respect to their involvement in the publication. The authors also declare that they do not have any financial or other relations (e.g., directorship, consultancy or speaker fee) with companies, trade associations, unions or groups (including civic associations and public interest groups) that may gain or lose financially from the results or conclusions in the study. Sources of funding are acknowledged.

Comment in

Similar articles

See all similar articles

Cited by

  • Grandiose narcissism, unfounded beliefs, and behavioral reactions during the COVID-19 pandemic.
    Żemojtel-Piotrowska M, Sawicki A, Piotrowski J, Lifshin U, Kretchner M, Skowronski JJ, Sedikides C, Jonason PK, Adamovic M, Ahmed O, Atitsogbe KA, Al-Shawaf L, Appiah SCY, Ardi R, Azam U, Babakr ZH, Baldursson EB, Bălțătescu S, Bochaver K, Bolatov A, Bonato M, Bundhoo HY, Chaleeraktrakoon T, Chobthamkit P, Cowden RG, Counted V, de Clunie G, Dragova-Koleva S, Esteves CS, Gouveia VV, Gundolf K, Hamouda S, Haretche C, Jeong EHK, Iliško D, Malik NI, Aruta JJB, Jia F, Jovanović V, Jukić T, Jukić DP, Kamble SV, Khachatryan N, Klicperova-Baker M, Kogler C, Knezović E, Koralov M, Kovacs M, Eldesoki WLM, Fernandez AL, Liik K, Malik S, Maltby J, Malysheva K, Mamuti A, Mangafic J, Moon C, Milfont TL, Muehlbacher S, Najafi R, Özsoy E, Park J, de León PP, Solcova IP, Ramos-Diaz J, Ridic G, Riđić O, Samekin A, Spoto A, Starc A, Stefenel D, Trà KTT, Tiliouine H, Tomšik R, Torres-Marín J, Umeh CS, Wills-Herrera E, Wlodarczyk A, Vally Z, Vauclair CM, Yahiiaiev I, Zand S. Żemojtel-Piotrowska M, et al. Sci Rep. 2024 Jul 30;14(1):17503. doi: 10.1038/s41598-024-67954-2. Sci Rep. 2024. PMID: 39080302 Free PMC article.
  • Rates of Vaccination against COVID-19 in Psychiatric Outpatients.
    Bosnjak MC, Kuljancic D, Vejnovic AM, Hinic D, Knezevic V, Ratkovic D, Bosic V, Vasic V, Sakic B, Segan D, Savic P, Abazovic M, Comic M, Siladji D, Simic-Panic D, Ivetic Poledica O. Bosnjak MC, et al. J Pers Med. 2024 Jul 14;14(7):748. doi: 10.3390/jpm14070748. J Pers Med. 2024. PMID: 39064002 Free PMC article.
  • Effects of perceived risk of COVID-19 on fear among visiting workers: Mediating role of perceived stress.
    Baek EM, Jung HS, Kwon S, Hwang JH, Park JY. Baek EM, et al. Medicine (Baltimore). 2024 Jul 26;103(30):e38594. doi: 10.1097/MD.0000000000038594. Medicine (Baltimore). 2024. PMID: 39058863 Free PMC article.
  • COVID-19 Symptoms and Mental Health Outcomes among Italian Healthcare Workers: A Latent Class Analysis.
    Foti G, Merlo L, Finstad GL, Giorgi G. Foti G, et al. Healthcare (Basel). 2024 Jul 15;12(14):1403. doi: 10.3390/healthcare12141403. Healthcare (Basel). 2024. PMID: 39057546 Free PMC article.
  • The Motivation for COVID-19 Vaccination and Preventive Behavior.
    Hong JC, Wu TF, Tsai WL. Hong JC, et al. J Prev (2022). 2024 Jun 5. doi: 10.1007/s10935-024-00787-x. Online ahead of print. J Prev (2022). 2024. PMID: 38839737
See all "Cited by" articles

References

    1. Ahmadzadeh M, Ghamarani A, Samadi M, Shamsi A, Azizollah A. The investigation of validity and reliability of a scale of perceived vulnerability to disease in Iran. British Journal of Social Sciences. 2013;1:43–51.
    1. Baud, D., Qi, X., Nielsen-Saines, K., Musso, D., Pomar, L., & Favre, G. (2020). Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. Retrieved from. 10.1016/S1473-3099(20)30195-X. - PMC - PubMed
    1. Centers for Disease Control and Prevention (2020a). Coronavirus Disease 2019 (COVID-19): Manage anxiety & stress. Retrieved March 16, 2020, from: https://www.cdc.gov/coronavirus/2019-ncov/prepare/managing-stress-anxiet....
    1. Centers for Disease Control and Prevention (2020b). Coronavirus disease 2019 (COVID-19): Reducing stigma. Retrieved March 16, 2020, from: https://www.cdc.gov/coronavirus/2019-ncov/about/related-stigma.html.
    1. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19) Drug Discoveries & Therapeutics. 2020;14(1):58–60. doi: 10.5582/ddt.2020.01012. - DOI - PubMed

Publication types

LinkOut - more resources